Wrist conditions affect millions of people worldwide, often leading to severe pain, reduced functionality, and loss of independence.
Currently, wrist replacement implant failure can result from the prosthesis loosening from its bone fixation due to poor bone rejuvenation and necrosis, or failure to regain functional range of motion and gripping force to the wrist following surgery.
SUCCESSFUL WRIST IMPLANTS
ARE NOW IN YOUR HANDS
The WristArt wrist joint replacement implant enables near-normal range of motion
Watch Video
The Need
The solution
WristArt Preserves Natural Motion & Eliminates Pain
The WristArt, our Total Wrist Prosthesis preserves the joint’s natural biomechanical behavior. It enables near normal range of motion while preserving bone stock and maintaining critical blood flow to areas surrounding the prosthesis.
One Size Fits All
WristArt Implant
WristArt’s individual interconnecting components are implanted as a system. The components, which optimize load and distribute force in the joint to reduce risk of joint dislocation and device loosening, are much less invasive and shorten current surgery time.
The surgeons point of view
Significantly improve patient care in total wrist implants
WristArt is a bone-sparing implant that can be used as an intermediate surgical solution prior to conventional arthrodesis or other TWAs. Unlike other TWAs, using WristArt doesn’t “burn the last bridge” in terms of surgical alternatives. Should WristArt need to be removed, both arthrodesis and other TWA implants can be offered to patients.
The Patients point of view
Significantly improve the quality of life with total wrist transplants
Fibioseq Medical Ltd (Acre, Israel), a pioneering developer of orthopedic upper extremity implants, proudly announces the initiation of its first-in-human clinical study and the completion of the first surgery with WristArt. This marks a significant milestone in the field of wrist joint restoration. The groundbreaking procedure involves the implantation of WristArt, a wrist implant designed to alleviate pain, restore motion, and promote independence in individuals suffering from chronic and debilitating wrist conditions.
about us
Fibioseq Medical Limited develops orthopedic extremity implants.
The company’s mission is to alleviate pain, restore motion, and promote independence in individuals who suffer from chronic and debilitating wrist conditions due to disease or injury.
Fibioseq Medical holds registered patents in the US, Europe, China & Israel.
The company’s mission is to alleviate pain, restore motion, and promote independence in individuals who suffer from chronic and debilitating wrist conditions due to disease or injury.
Fibioseq Medical holds registered patents in the US, Europe, China & Israel.
Our mission is to significantly improve patient care in total wrist implants
in the media
Dr. Lauren Gorelick
CMO
Dr. Lauren Gorelick is certified orthopedic and hand surgeon, foot and ankle surgeon, specialist
in orthopedic and sport trauma, medical consultant to the courts.
Dr. Gorelick has 35 years of experience as an orthopedic and orthopedic trauma surgeon specializing in hand surgery and joint repair. He acts as a consultant for medical students at the Faculty of Medicine in Safed, which is affiliated with Bar-Ilan University.
Harel Manor
CEO
Harel Manor is a serial healthcare entrepreneur with more than 18 years of senior management experience.
Harel holds an M.A. from Johns Hopkins University and a B.Sc. from the University of Maryland. Formerly, he co–founded and was the CEO of Maayan Advanced Medical Center for eye surgery, which was sold in 2019 to the Enaim Group. He was the Associate Dean for Administration at the Bar-Ilan University Faculty of Medicine in Safed and the regional manager for Leumit Health Services, an Israeli HMO. Prior to this role, he spent seven years in the Israeli Diplomatic Corp in Washington.
Ofer Vikinsky
CTO
Ofer is a biomedical engineer, entrepreneur, founder, and manager of early-stage medical device startup companies.
Ofer holds an M.B.A. from the Technion, Israel Institute of Technology and B.Sc. in biomedical engineering from Ben-Gurion University. Ofer brings over 15 years of managerial and hands-on experience in the development of medical devices and is an expert in designing and manufacturing orthopedic implants and surgical instruments. He co-founded Orthospin Ltd., a developer of robotic external fixation system for deformity correction and limb lengthening, acquired by Johnson & Johnson in 2021. He also co-founded and was the former CEO of Triomed Medical Ltd., an engineering firm specializing in repairing surgical instruments and endoscopes.
Tal Caspi
Project Manager
Tal holds a Bachelor of Science in Biomedical Engineering from Tel Aviv University.
He brings over 14 years of experience in the research and development of medical devices and implants, he previously led the development team at Active implants Ltd.Tal has been instrumental in developing CE and FDA-cleared implants, with some of these innovations later acquired. Skilled in managing the entire product life cycle from concept through commercialization.
Shiri Pendler
Chief Clinical Research Officer
Shiri is a biomedical engineer with more than 15 years of experience in the medical device industry.
She has led complex global clinical studies for both for PMA and 510K medical devices at all stages of the product development process. Shiri has vast experience in designing, planning, and executing diverse clinical studies including FDA approval, post-market studies, conceptualization and feasibility, and human trial in Israel, the US, and Europe.
Orit Topaz, PhD
RA QA Director
Orit has a strong medical background with extensive experience in obtaining sales approvals for medical devices in both global companies and startups.
In recent years, she has led the implementation of the new regulation 2017/745 and has built Quality Management Systems (QMS) and Technical Files (TF). Orit holds a Ph.D. in Medical Sciences and a Master's degree in Endocrinology.
Our Team
Prof. Arnold-Peter Weiss
MD
Prof. Weiss is an internationally recognized hand surgeon and professor of orthopedics at The Warren Alpert Medical School Brown University.
He specializes in hand & wrist
reconstruction, with a particular interest in finger and wrist joint replacement surgery. He lectures extensively, both nationally &
internationally, on hand surgery and has been awarded the AOA North American Fellowship, the American-British-Canadian Fellowship, & the Sterling Bunnell Fellowship.
Dr. Jeffrey Yao
MD
Dr Yao is an orthopedic surgeon in Redwood City, California & is affiliated with Stanford Healthcare – Stanford Hospital.
His orthopedic surgery residency was completed at the Albert Einstein College of Medicine NSUH-LIJ Health System in New York in 2004. He has been Editor-in-Chief of the Yearbook of Hand and Upper Limb Surgery since 2009. He is also on the editorial board of HAND surgery.
Dr. Ingo Schmidt
MD
Dr. Schmidt graduated his education as a General, Trauma, Orthopaedic, Hand and Plastic Surgeon at the Friedrich-Schiller-University Hospital Jena (Germany) between 1990 and 1999.
During this time, he developed and patented a novel external dynamic minifixateur for the hand (PMIDs 8585344_1995 and 33173674_2020), and he received his MD title in 1994 for his electromyographic studies following proximal biceps tendon ruptures (PMID 7502385_1995). Dr. Schmidt then specialized in particular in the field of joint replacements for the entire hand. He is an internationally recognized specialist for Total Wrist Replacement with many valuable publications and presentations at congresses and symposia, and he works as reviewer for various scientific journals.
A recent publication by Dr. Schmidt in 2024 dealing with TWA was nominated and recognized as a scientifically outstanding contribution by the internationally acting. Canadian non-profit science platform “Science Featured Series”
Miri Tal
Advisor
Miri Tal has more than 30 years of experience in top executive positions in medical device and high-tech companies.
Miri has expertise in building company infrastructures, processes, and resources from start through development, production scale-up, product launch, and commercial phase including marketing and sales buildup and growth. Miri has extensive experience in leading products toward FDA PMA approval, 510k approvals and CE certificate etc., including clinical trials. For the last 11 years, Miri was the corporate COO and President of the Israeli site of Premia Spine, which specializes in orthopedic spine implants. Miri holds an M.B.A. from Bar-Ilan University and B.A. in business and economics from the Hebrew University.
Liron Fendell
Advisor
Liron Fendell is an operating partner at investment firm Adam Partners.
She is the former
CEO of Nutritional Growth Solutions (ASX: NGS), a publicly listed healthcare company created by Clalit Health Services. Liron has extensive experience with consumer healthcare, clinical trials, insurance reimbursements, as well as with venture capital and the capital market.
Liron holds a Bachelor of Law and an MBA from Tel Aviv University.
AdvisorY BOARD
